Novel sulfonamides bearing pyrrole and pyrrolopyrimidine moieties as carbonic anhydrase inhibitors: Synthesis, cytotoxic activity and molecular modeling
Loading...
Date
2014-11
Journal Title
Journal ISSN
Volume Title
Type
Article
Publisher
Elsevier
Series Info
European Journal of Medicinal Chemistry;Volume 87, 24 November 2014, Pages 186-196
Doi
Scientific Journal Rankings
Abstract
Novel sulfonamides bearing pyrrole and pyrrolopyrimidine moieties as carbonic anhydrase inhibitors: synthesis, cytotoxic activity and molecular modeling
المؤلفون
Mostafa M Ghorab, Mariangela Ceruso, Mansour S Alsaid, Yassin M Nissan, Reem K Arafa, Claudiu T Supuran
تاريخ النشر
2014/11/24
مجلة
European journal of medicinal chemistry
المجلد
87
الصفحات
186-196
الناشر
Elsevier Masson
الوصف
Novel pyrrole and pyrrolopyrimidine scaffold-based sulfonamides were designed and synthesized. The carbonic anhydrase (CA) inhibition ability of all derivatives was assessed against the human (h) cytosolic isoforms hCA I and II and the transmembrane, tumor-associated isoforms hCA IX and XII. Some of these sulfonamides were 6–8 fold more potent than the reference drug acetazolamide (AZA, Ki = 5.7 nM)) against hCA XII showing subnanomolar activity. The in vitro cytotoxicity of these derivatives was evaluated against MCF-7, where some derivatives were more cytotoxic than doxorubicin (IC50 = 8.02 μM) displaying IC50 values between 6.46 and 7.56 μM. Docking of these sulfonamides with CA XII was performed and their binding modes were comparable with that of AZA.
Description
MSA GOOGLE SCHOLAR
Keywords
university of Cytotoxic activity, Carbonic anhydrase, Sulfonamides, Pyrrolopyrimidines, Pyrroles